Acne Treatment Market Size To Grow USD 15.53 Billion by 2032

The global acne treatment market was valued at USD 9.68 billion in 2022 and it is predicted to surpass around USD 15.53 billion by 2032 with a CAGR of 4.84% from 2023 to 2032.

Key Pointers

• North America region is expected to grow at the fastest CAGR of 35.93% in 2022.
• By Product, the retinoid segment contributed the largest market share of 26% in 2022.
• By Route of Administration, the topical segment generated the maximum market share of 36% in 2022.
• By End User, the skincare clinics segment registered the highest market share of 38%.

The global acne treatment market has witnessed remarkable growth over the past decade, driven by increasing incidences of acne-related skin issues and a growing awareness about skincare. Acne, a common skin condition affecting adolescents and adults alike, has spurred a lucrative market for various treatment solutions. This overview delves into the fundamental aspects shaping the acne treatment market, shedding light on its current state, trends, and key drivers.

Market Growth

The growth of the acne treatment market is propelled by several key factors. Firstly, the increasing prevalence of acne-related skin issues, influenced by changing lifestyles and environmental factors, has led to a rising demand for effective treatment solutions. Secondly, advancements in skincare technologies, including innovative topical treatments and minimally invasive procedures, have significantly enhanced the efficacy of acne treatments, attracting more consumers. Moreover, heightened consumer awareness about skincare, coupled with easy access to information through digital platforms, has empowered individuals to seek timely and suitable acne treatments. Additionally, the strategic initiatives of market players, such as research and development activities, mergers, and acquisitions, play a pivotal role in driving market growth. These factors, combined with the growing disposable incomes and a focus on personal grooming, create a conducive environment for the continuous expansion of the acne treatment market.

Get a Sample: https://www.visionresearchreports.com/report/sample/40889

Report Scope of the Acne Treatment Market

Read More: https://www.heathcareinsights.com/veterinary-cro-and-cdmo-market/

Market Dynamics

Drivers

Increasing incidence of acne vulgaris:

Acne vulgaris is a skin ailment that affects 9.5% of people worldwide, mostly young people. Across all racial groupings, it affects more than 95% of men and 85% of women. According to the American Academy of Dermatology Association (AADA), 55 million Americans suffer from acne each year, making it the most common skin disorder in the country. Additionally, it stated that 86% of those under the age of thirty and fourteen have acne. The disorder begins when the androgen (or estrogen, in the case of women) levels peak during puberty and cause the oil glands under the skin to expand.

Restraints

Regarding the product’s safety:

The side effects of acne treatments differ based on the medication’s potency and the approach chosen. Skin irritation and dryness are the most commonly reported negative effects of topical acne medications. Oral medications may have more serious side effects. Antibiotics might upset a patient’s stomach or make them feel lightheaded and dizzy. Furthermore, severe adverse effects are possible with oral isotretinoin, particularly in pregnant women. It has been shown that infants whose mothers took isotretinoin during their pregnancies had severe congenital impairments. The medication may also affect liver function, cholesterol levels, and increase the likelihood of suicidal thoughts and despair. It is predicted that safety concerns regarding acne treatment solutions will impede market growth.

Opportunities

Growing knowledge of new and existing acne treatment options:

There is an immense global need for minimally invasive cosmetic treatment methods. Dermatologists use topical or less invasive methods rather than surgery to address skin conditions. The need for treatments for face and skin-related issues is increasing due to greater patient-doctor connections, well-documented policies, and increased process understanding. This has pushed the usage of less painful aesthetic combination therapy approaches.

Product Insights

The retinoid segment contributed the largest market share of 26% in 2022. Divided into categories such as antibiotics, isotretinoin, retinoids, and others is the product type segment. Retinoids are now widely used by people to clear their skin of excess oil and dust that has clogged their open pores. The method is a large market sector because it is regarded as safe and has little negative effects.

By Acne Type

Acne, a common skin condition affecting millions of people worldwide, manifests in various forms, ranging from mild blemishes to severe, inflamed lesions. However, the market has seen a surge in demand for treatments catering to mild and moderate acne cases, as these are the most prevalent types among the affected population.

By Drug Type

Over the Counter (OTC) products and prescription-based treatments. Over the Counter medications are readily available to consumers without the need for a doctor’s prescription. These products typically include topical creams, gels, cleansers, and spot treatments containing active ingredients like benzoyl peroxide, salicylic acid, or sulfur.

prescription-based acne treatments are formulated with stronger and more potent ingredients, often requiring the supervision and prescription of a qualified healthcare professional. Dermatologists commonly prescribe topical medications like retinoids, antibiotics, and combination products that contain multiple active ingredients to address various acne-related factors.

Route of Administration Insights

The topical segment generated the maximum market share of 36% in 2022. Topical, injectable, and oral medications are separated out under the method of delivery section. Due to the growing number of companies producing topical solutions for acne treatment, the topical segment is expected to dominate the market over the projected years. This is because patients are predominantly drawn to topical treatments because they are comfortable and easily accessible.

End Use Insights

The skincare clinics segment registered the highest market share of 38%. Specialty centers, skincare clinics, and hospitals make up the end user category. Over the projected years, the skin care clinics segment is expected to increase at a rapid pace. Individuals who live in Tier 1 cities are experiencing severe skin conditions because they are constantly exposed to dust, pollution, and other environmental factors, such as working in an air-conditioned environment.

Regional Insights

North America region is expected to grow at the fastest CAGR of 35% in 2022. In North America, the market is driven by high healthcare spending, advanced dermatological technologies, and a significant focus on personal grooming. The region’s well-established healthcare facilities and consumer awareness contribute to the steady demand for acne treatments. Europe, with its robust pharmaceutical industry, witnesses a growing emphasis on research and development, leading to the introduction of innovative acne treatment products. Additionally, the increasing prevalence of acne among adolescents and adults sustains market growth in this region.

Asia-Pacific emerges as a promising market for acne treatment, driven by factors such as rising disposable incomes, changing lifestyles, and a growing youth population. Countries like China and India are witnessing a surge in demand for skincare products, including acne treatments, due to increased awareness and urbanization. The region also benefits from the availability of cost-effective treatment options, fostering market expansion.

Recent Developments

In June 2020: Bausch Health Companies Inc. founded ARAZLO lotion in the United States for patients nine years of age and older suffering from acne vulgaris.

In June 2021: Almirall declared the launch of Seysara, a novel tetracycline-derived oral antibiotic and the first to be designed particularly for treating acne. The product is commercially founded in the United States market.

In January 2022: Galderma S.A. concluded its purchase of ALASTIN Skincare, Inc. after receiving an antitrust clearance from federal authorities of the U.S. Rising consumer interest and increasing popularity of aesthetic skin care procedures had led to an advancement in demand for valuable products.

Acne Treatment Market Segmentations:

By Product

• Therapeutic Treatment
  • Antibiotics
  • Retinoid Therapy
  • Hormonal Drugs
  • Anti-inflammatory Drugs
  • Chemical Peels
• Devices
  • Laser Devices
  • Radio frequency Devices

By Acne Type

• Moderate
• Mild
• Moderate To Severe

By Treatment

• Medication
• Therapeutic Devices

By Drug Type

• Over the Counter (OTC)
• Prescription

By Gender

• Women
• Men

By Route of Administration

• Topical
• Oral
• Injectable

By End User

• Dermatology Clinics
• MedSpa

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/40889

You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308

Blog: https://www.novaoneadvisor.com/

Web: https://www.visionresearchreports.com/